UFP Technologies, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
UFP Technologies, Inc. (UFPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $1.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-06
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $1.20M, a 71.43% increase year-over-year.
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $500.00K, a 66.67% decline year-over-year.
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was -$300.00K, a 137.50% decline year-over-year.
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $200.00K.
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $2.10M, a 40.00% increase from fiscal 2024.
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $1.50M, a 50.00% decline from fiscal 2023.
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $3.00M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.70M 10-Q · filed 2026-08-06 | $1.40M derived: sum of 3 quarters · filed 2026-08-06 | $1.60M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-08 | $200.00K derived: sum of 2 quarters · filed 2026-05-08 | $400.00K derived: sum of 3 quarters · filed 2026-05-08 | $1.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$100.00K derived: sum of 2 quarters · filed 2026-02-27 | $600.00K derived: sum of 3 quarters · filed 2026-08-06 | $2.10M 10-K · filed 2026-02-27 |
| 2025-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $900.00K derived: sum of 2 quarters · filed 2026-08-06 | $2.40M 10-Q · filed 2025-11-07 | $3.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.20M 10-Q · filed 2026-08-06 | $3.00M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-03-31 | $1.50M 10-Q · filed 2026-05-08 | $2.30M derived: sum of 2 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.50M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $700.00K 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $3.00M 10-K · filed 2026-02-27 | |||
| 2018-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $686.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.20M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $486.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.00M 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $514.00K 10-Q · filed 2018-05-10 | |||
| 2017-09-30 | $186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $393.00K derived: sum of 2 quarters · filed 2018-11-09 | $577.00K 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $391.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $184.00K 10-Q · filed 2018-05-10 | |||
| 2016-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $564.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $518.00K 10-Q · filed 2017-08-09 | |||
| 2015-09-30 | $989.00K 10-Q · filed 2016-11-09 | |||
| 2013-09-30 | $2.00M 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |